Scientist I - RNA Therapeutic Discovery (4-month contract) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Ascidian Therapeutics · 1 month ago

Scientist I - RNA Therapeutic Discovery (4-month contract)

positionBoston, MA
timeContract
remoteOnsite
senioritySenior Level
date5+ years exp

Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. They are seeking a Contract Scientist I to join the RNA Therapeutic Discovery Team, where the individual will design and execute experiments to advance novel RNA therapeutics.

BiotechnologyGeneticsMedicalNeuroscienceTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Design, execute, and interpret experiments to improve therapeutic performance of designer RNA molecules
Support research activities that contribute to the company's intellectual property portfolio
Interpret data, generate figures, and clearly communicate findings to the team
Maintain accurate and detailed records using ELN

Qualification

Mammalian cell cultureAAV vectors expertiseMolecular biology techniquesRNA extractionQuantificationProtein extractionWestern blotEagerness to learnProblem solving skillsCommunication skills

Required

Extensive hands-on experience with mammalian cell culture, particularly iPSCs and iPSC-derived cell models
Proven expertise in working with AAV vectors, including handling, titration, and transduction in challenging cell types (e.g., iPSC-derived cells)
Proficiency with basic molecular biology techniques: plasmid design, cloning, primer design and PCR, DNA isolation, gel electrophoresis, Sanger sequencing analysis
Proficiency with RNA extraction and quantification by qPCR and ddPCR
Protein extraction and western blot
Eagerness to learn and receptive to feedback
Demonstrated problem solving and troubleshooting skills
Ph.D. in molecular/cellular biology, biochemistry, genetics, or related field with 5+ years relevant laboratory experience
Background in RNA, cardiac biology, muscle biology, and/or neuroscience

Company

Ascidian Therapeutics

twittertwitter
company-logo
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
dateFounded in 2020
location
Boston, Massachusetts, USA
people-size11-50 employees
web-link
https://www.ascidian-tx.com/

H1B Sponsorship

Ascidian Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (3)

Funding

Current Stage
Early Stage
Total Funding
$90M
Key Investors
Apple Tree Partners
2023-11-08Series A· $40M
2022-10-11Series A· $50M
2021-01-01Seed

Leadership Team

leader-logo
Michael Ehlers
Founder, President, and Chief Executive Officer
linkedin

Recent News

Business Wire
Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease
2026-01-07
citybiz
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer
2025-06-25
PR Newswire
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease
2025-06-24
Company data provided by crunchbase